Managing mood disorders and comorbid personality disorders

Current Opinion in Psychiatry

Volumn 18, Issue 1, 2005, Pages 27-31

  Bajaj, Priya ^a   Tyrer, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Depression; Mood disorder; Outcome; Personality disorder

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; IMIPRAMINE; NEUROLEPTIC AGENT; SERTRALINE;

BEHAVIOR THERAPY; BIPOLAR DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG EFFICACY; HUMAN; MOOD DISORDER; OUTCOMES RESEARCH; PATIENT EDUCATION; PERSONALITY DISORDER; REVIEW; TREATMENT INDICATION;

EID: 14744287172     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Bieling PJ, MacQueen GM, Marriot MJ, et al. Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord 2003; 5:14-21.
2. Leverich GS, Altshuler LL, Frye MA, et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry 2003; 64:506-515.
3. George EL, Miklowitz DJ, Richards JA, et al. The comorbidity of bipolar disorders: prevalence and clinical correlates. Bipolar Disord 2003; 5:115-122.
4. Shea MT, Widiger TA, Klein MH. Comorbidity of personality disorders and depression: implications for treatment. J Consult Clin Psych 1992; 60:857-868.
5. Tyrer P, Gunderson J, Lyons M, Tohen M. Special Feature: Extent of comorbidity between mental state and personality disorders. J Pers Disord 1997; 11:242-259.
6. Costa PT, McCrea RR. The five-factor model of personality and its relevance to personality disorders. J Pers Disord 1992; 6:343-359.
7. Cloninger CR, Svrakic DM, Pryzbeck TR. A psycrobiological model of temperament and character. Arch Gen Psychiatry 1993; 50:975-990.
8. Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry 2002; 159:359-371.
9. Tyrer P, Seivewright N, Ferguson B, et al. The Nottingham Study of Neurotic Disorder: relationship between personality disorder and symptoms. Psychol Med 1990; 20:423-431.
10. Hansen PB, Wang AG, Stage KB, Kragh-Sorenssen P. Comorbid personality disorder predicts suicide after major depression: a 10-year follow-up. Acta Psychiatr Scand 2003; 107:436-440.
11. Seivewright H, Tyrer P, Johnson T. Prediction of outcome in neurotic disorder: a five year prospective study. Psychol Med 1998; 28:1149-1157.
12. Bieling PJ, MacQueen GM, Marriot MJ, et al. Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms. Bipolar Disord 2003; 5:14-21.
13. Colom F, Vieta E, Martinez-Aran A, et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61:549-555.
14. Schou M. No help from lithium? About patients who might have been but were not helped by prophylactic lithium treatment. Compr Psychiatry 1988; 29:83-90.
15. O'Connell RA, Mayo JA, Eng LK, et al. Social support and long-term lithium outcome. Br J Psychiatry 1985; 147:272-275.
16. Barbato N, Hafner RJ. Comorbidity of bipolar and personality disorders. Aust N Z J Psychiatry 1998; 32:276-280.
17. Dunayevich E, Sax KW, Keck PE, et al. Twelve-month outcome in bipolar patients with and without personality disorders. J Clin Psychiatry 2000; 61:134-139.
18. Vieta E, Colom F. Personality disorders in bipolar II patients. J Nerv Ment Dis 1999; 187:245-248.
19. Cyranowski JM, Frank E, Winter E, et al. Personality pathology and outcome in recurrently depressed women over 2 years of maintenance interpersonal psychotherapy. Psychol Med 2004; 34:659-669 This study is the first of its kind to test the effects of personality pathology on maintenance treatment outcome for depression and is therefore notable. However, the lack of inclusion of the full Structured Clinical Interview for DSM-IV II assessment during the acute mood episode limited the inferences made about the veracity or utility of personality disorder assessments. Furthermore, lack of a no-treatment control condition made it difficult to rule out a simple effect of time on personality pathology.
20. Colom F, Vieta E, Sanchez-Moreno J, et al. Psychoeducation in bipolar patients with comorbid personality disorders. Bipolar Disord 2004; 6:294-298. This study was a subanalysis from a single-blind, randomized prospective clinical trial. Despite the small size, the results were significantly in favor of psychoeducation, with a 100% relapse rate among the control group. Overall, it paved the way forward for combined therapy as a useful modality in the treatment of comorbidity in bipolar patients.
21. Preston GA, Marchant BK, Reimherr FW, et al. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 2004; 79:297-303. This study retrospectively examined the incidence of borderline personality dimensions in a cohort of patients participating in multi-center studies. Suicidality/self harm was one of the affective dimensions defined, which is one of the common measures of outcome in borderline personality disorder patients. A major limitation was stringent selection criteria that even included severe personality disorder, which greatly reduces the external validity and generalizability of the sample.
22. Reich JH, Vasile RG. Effect of personality disorders on the treatment outcome of axis I conditions: an update. J Nerv Ment Dis 1993;181:475-484.
23. Mulder RT. Depression and personality disorder. Curr Psychiatry Rep 2004; 6:51-57. An interesting review of the ongoing conceptual and theoretical difficulties in studying the relationship between depression and personality disorder. It contradicted the simplistic view of personality disorders being pervasive and affective disorders episodic. Various studies were reviewed to support the theory that personality symptoms may change over time.
24. Wilberg T, Friis S, Karterud S, et al. Patterns of short-term course in patients treated in a day unit for personality disorders. Compt Psychiatry 1998; 39:75-84.
25. Sato T, Sakado K, Sato S. Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression? Acta Psychiatr Scand 1993; 88:342-349.
26. Peselow ED, Sanfilipo MP, Fieve RR, Gulbenkian G. Personality traits during depression and after clinical recovery. Br J Psychiatry 1994; 164:349-354.
27. Russell JM, Kornstein SG, Shea T, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry 2003; 64:554-561. A large, double-blind, randomized controlled trial which showed a modest correlation between early age of onset and axis II comorbidity, contrary to previous research findings. It differed from previous reported research as it separately examined the association between axis II comorbidity and time of onset and depression subtype in a large depression sample that was homogenous for duration of illness. The convenience sampling methods employed were a major limitation of this study.
28. Viinamki H, Tanskanen A, Koivumaa-Honkanen H, et al. Cluster C personality disorder and recovery from major depression: 24-month prospective follow-up. J Pers Disord 2003; 17:341-350. This study involved a 24-month prospective follow-up of major depression patients with and without cluster C personality disorder. It was the first of its kind with a long follow-up period which used major depression as a criterion for recovery. The assessment of patients at regular intervals was a major strength of the study despite the small sample size. Cluster C emerged as an important risk factor for non-recovery from major depression.
29. Thomson LW, Gallagher D, Czirr R. Personality disorder and outcome in the treatment of late-life depression. J Geriatr Psychiatry 1988; 21:133-146.
30. Kool S, Dekker J, Duijsens IJ, et al. Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders. Harv Rev Psychiatry 2003; 11:133-141. This study emphasized the role of combined therapy in the treatment of patients with comorbid personality disorders. The trial was conducted over 6 months using a short-term structured therapy which produced favourable results. The sample included relatively young and highly educated individuals which may have affected the results.
31. Kool S, Dekker J, Duijsens IJ, et al. Changes in personality pathology after pharmacotherapy and combined therapy for depressed patients. J Pers Disord 2003; 17:60-73. A randomized trial conducted over 40 weeks with a large sample size. This study was able to demonstrate a differential response among cluster B and C patients, the latter showing the most striking reduction in personality pathology. A short (16-session) psychodynamic supportive psychotherapy model was used as a treatment arm along with three different classes of antidepressants, namely fluoxetine, amitryptiline and moclobemide.
32. Reich J. The effect of axis II disorders on the outcome of treatment of anxiety and unipolar depressive disorders: a review. J Pers Disord 2003; 17:387-405.
33. Seivewright H, Tyrer P, Johnson T. Change in personality status in neurotic disorders. Lancet 2002; 359:2253-2254.